Studying de-implementation in health: An analysis of funded research grants

Implementation Science

Volumn 12, Issue 1, 2017, Pages

  Norton, Wynne E ^a   Kennedy, Amy E ^a   Chambers, David A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

De adoption; De implementation; De prescribe; Decrease use; Disincentivize; Disinvestment; Evidence based; Exnovation; Implementation research; Implementation science; Low value; Medical reversal; Overuse; Portfolio analysis

Indexed keywords

ECONOMICS; FINANCIAL MANAGEMENT; HEALTH SERVICE; HUMAN; MEDICAL RESEARCH; PREVENTION AND CONTROL; PROCEDURES; UNITED STATES;

BIOMEDICAL RESEARCH; FINANCING, ORGANIZED; HEALTH SERVICES MISUSE; HUMANS; UNITED STATES;

EID: 85037372595     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-017-0655-z     Document Type: Article

References (69)

1. Martin AB, Hartman M, Benson J, Catlin A. National Health Spending in 2014: faster growth driven by coverage expansion and prescription drug spending. Health Aff (Millwood). 2016;35:150-60.
2. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307:1513-6.
3. Bentley TG, Effros RM, Palar K, Keeler EB. Waste in the US health care system: a conceptual framework. Milbank Q. 2008;86:629-59.
4. Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, Landon BE, Zezza MA, Schmidt H, Saini V, Elshaug AG. Setting a research agenda for medical overuse. BMJ. 2015;351:h4534.
5. Morgan DJ, Dhruva SS, Wright SM, Korenstein D. 2016 update on medical overuse: a systematic review. JAMA Intern Med. 2016;
6. Sinha P. Don't just do something, stand there! JAMA Intern Med. 2017;
7. Keyhani S, Falk R, Howell EA, Bishop T, Korenstein D. Overuse and systems of care: a systematic review. Med Care. 2013;51:503-8.
8. Korenstein D, Falk R, Howell EA, Bishop T, Keyhani S. Overuse of health care services in the United States: an understudied problem. Arch Intern Med. 2012;172:171-8.
9. Baxi SS, Kale M, Keyhani S, Roman BR, Yang A, Derosa AP, Korenstein D. Overuse of health Care Services in the Management of cancer: a systematic review. Med Care. 2017;55:723-33.
10. Lyu H, Xu T, Brotman D, Mayer-Blackwell B, Cooper M, Daniel M, Wick EC, Saini V, Brownlee S, Makary MA. Overtreatment in the United States. PLoS One. 2017;12:e0181970.
11. Hicks LK. Reframing overuse in health care: time to focus on the harms. J Oncol Pract. 2015;11:168-70.
12. Lipitz-Snyderman A, Bach PB. Overuse of health care services: when less is more. More or less. JAMA Intern Med. 2013;173:1277-8.
13. Chassin MR, Galvin RW. The urgent need to improve health care quality: Institute of Medicine National Roundtable on health care quality. JAMA. 1998;280:1000-5.
14. Cifu AS, Prasad VK. Medical debates and medical reversal. J Gen Intern Med. 2015;30:1729-30.
15. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307:1801-2.
16. Prasad V, Cifu A. Medical reversal: why we must raise the bar before adopting new technologies. Yale J Biol Med. 2011;84:471-8.
17. Prasad V, Ioannidis JP. Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implement Sci. 2014;9:1.
18. Prasad VK, Cifu AS. Ending medical reversal: improving outcomes, saving lives: JHU Press; 2015.
19. Colla CH. Swimming against the current-what might work to reduce low-value care? N Engl J Med. 2014;371:1280-3.
20. Schwartz AL, Landon BE, Elshaug AG, Chernew ME, McWilliams JM. Measuring low-value care in Medicare. JAMA Intern Med. 2014;174:1067-76.
21. Niven DJ, Mrklas KJ, Holodinsky JK, Straus SE, Hemmelgarn BR, Jeffs LP, Stelfox HT. Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC Med. 2015;13:255.
22. McKibbon KA, Lokker C, Wilczynski NL, Ciliska D, Dobbins M, Davis DA, Haynes RB, Straus SE. A cross-sectional study of the number and frequency of terms used to refer to knowledge translation in a body of health literature in 2006: a tower of Babel? Implement Sci. 2010;5:16.
23. Montini T, Graham ID. "entrenched practices and other biases": unpacking the historical, economic, professional, and social resistance to de-implementation. Implement Sci. 2015;10:24.
24. Niven DJ, Leigh JP, Stelfox HT. Ethical considerations in the de-adoption of ineffective or harmful aspects of healthcare. Healthc Manage Forum. 2016;29:214-7.
25. Covinsky KE, Redberg RF. An intervention to reduce use of low-value imaging tests. JAMA Intern Med. 2016;176:198.
26. Clyne B, Smith SM, Hughes CM, Boland F, Bradley MC, Cooper JA, Fahey T. Effectiveness of a multifaceted intervention for potentially inappropriate prescribing in older patients in primary care: a cluster-randomized controlled trial (OPTI-SCRIPT study). Ann Fam Med. 2015;13:545-53.
27. Colla CH, Mainor AJ, Hargreaves C, Sequist T, Morden N. Interventions aimed at reducing use of low-value health services a systematic review. Med Care Res Rev. 2016:1077558716656970.
28. Silverstein W, Lass E, Born K, Morinville A, Levinson W, Tannenbaum C. A survey of primary care patients' readiness to engage in the de-adoption practices recommended by choosing wisely Canada. BMC Res Notes. 2016;9:301.
29. Types of Grant Programs [ http://grants.nih.gov/grants/funding/funding_program.htmRSeries ].
30. Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of 'deprescribing'with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254-68.
31. Thompson W, Farrell B. Deprescribing: what is it and what does the evidence tell us? The Canadian journal of hospital pharmacy. 2013;66:201.
32. Elshaug AG, Hiller JE, Tunis SR, Moss JR. Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust New Zealand Health Policy. 2007;4:23.
33. Garner S, Littlejohns P. Disinvestment from low value clinical interventions: NICEly done? BMJ (Online). 2011;343
34. Rodriguez HP, Henke RM, Bibi S, Ramsay PP, Shortell SM. The Exnovation of chronic care management processes by physician organizations. Milbank Q. 2016;94:626-53.
35. Davidoff F. On the undiffusion of established practices. JAMA Intern Med. 2015;175:809-11.
36. Alfano CM, Bluethmann SM, Tesauro G, Perna F, Agurs-Collins T, Elena JW, Ross SA, O'Connell M, Bowles HR, Greenberg D, Nebeling L. NCI funding trends and priorities in physical activity and energy balance research among cancer survivors. J Natl Cancer Inst. 2016;108
37. Ramirez AS, Galica K, Blake KD, Chou WY, Hesse BW. Cancer communication science funding trends, 2000-2012. J Natl Cancer Inst Monogr. 2013;2013:133-9.
38. Neta G, Sanchez MA, Chambers DA, Phillips SM, Leyva B, Cynkin L, Farrell MM, Heurtin-Roberts S, Vinson C. Implementation science in cancer prevention and control: a decade of grant funding by the National Cancer Institute and future directions. Implement Sci. 2015;10:4.
39. Office of Portfolio Analysis [ https://dpcpsi.nih.gov/opa ].
40. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
41. Norton WE, Lungeanu A, Chambers DA, Contractor N. Mapping the growing discipline of dissemination and implementation science in health. Scientometrics. 2017;
42. Gallagher P, O'Mahony D. STOPP (screening tool of older persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with beers' criteria. Age Ageing. 2008;37:673-9.
43. O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014:afu145.
44. Campanelli CM. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 beers criteria update expert panel. J Am Geriatr Soc. 2012;60:616.
45. Tinkle M, Kimball R, Haozous EA, Shuster G, Meize-Grochowski R. Dissemination and implementation research funded by the US National Institutes of Health, 2005-2012. Nurs Res Pract. 2013;2013:909606.
46. Gavini N, Hoots WK, Mensah GA, Hanspal M. An analysis of the NIH-supported sickle cell disease research portfolio. Blood Cells Mol Dis. 2015;54:198-205.
47. Richmond NA, Lamel SA, Davidson JM, Martins-Green M, Sen CK, Tomic-Canic M, Vivas AC, Braun LR, Kirsner RS. US-national institutes of health-funded research for cutaneous wounds in 2012. Wound Repair Regen. 2013;21:789-92.
48. Colla CH, Morden NE, Sequist TD, Schpero WL, Rosenthal MB. Choosing wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med. 2015;30:221-8.
49. Tabak RG, Ramsey AT, Baumann AA, Kryzer E, Montgomery K, Lewis E, Padek M, Powell BJ, Brownson RC. Variation in research designs used to test the effectiveness of dissemination and implementation strategies: a systematic review. In: Annual conference on the science of dissemination and implementation in health. Washington, D.C.; 2015.
50. Norton WE, Harris R, Kramer BK. De-implementation: exploring multi-level strategies for reducing Overdiagnosis and overtreatment. In: Preventing Overdiagnosis conference. Barcelona, Spain; 2016.
51. Boyce C, Mensah GA, Science CfTRaI, National Health L, and Blood Institute: De-implementation scientific challenges and prospects: to have, to hold, or to let go. 2017.
52. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-45.
53. Lohr KN, Brook RH, Kamberg CJ, Goldberg GA, Leibowitz A, Keesey J, Reboussin D, Newhouse JP. Use of medical care in the RAND health insurance experiment: diagnosis-and service-specific analyses in a randomized controlled trial. Med Care. 1986;24:S1-S87.
54. Kahan JP, Bernstein SJ, Leape LL, Hilborne LH, Park RE, Parker L, Kamberg CJ, Brook RH. Measuring the necessity of medical procedures. Med Care. 1994;32:357-65.
55. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care. 1986;2:53-63.
56. Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, Turner J, Rochon P, Silvius J. An ecological approach to reducing potentially inappropriate medication use: Canadian Deprescribing network. Can J Aging. 2017;36:97-107.
57. Finkelstein A, Taubman S, Wright B, Bernstein M, Gruber J, Newhouse JP, Allen H, Baicker K, Group OHS. The Oregon health insurance experiment: evidence from the first year. Q J Econ. 2012:qjs020.
58. Allen H, Baicker K, Taubman S, Wright B, Finkelstein A. The Oregon health insurance experiment: when limited policy resources provide research opportunities. J Health Polit Policy Law. 2013;38:1183-92.
59. Baicker K, Taubman SL, Allen HL, Bernstein M, Gruber JH, Newhouse JP, Schneider EC, Wright BJ, Zaslavsky AM, Finkelstein AN. The Oregon experiment-effects of Medicaid on clinical outcomes. N Engl J Med. 2013;368:1713-22.
60. Brownson RC, Chriqui JF, Stamatakis KA. Understanding evidence-based public health policy. Am J Public Health. 2009;99:1576-83.
61. Purtle J, Peters R, Brownson RC. A review of policy dissemination and implementation research funded by the National Institutes of Health, 2007-2014. Implement Sci. 2016;11:1.
62. Zelmer J. De-prescribing: when less is more in healthcare. Healthc Policy. 2016;11:6-10.
63. Aron DC, Lowery J, Tseng CL, Conlin P, Kahwati L. De-implementation of inappropriately tight control (of hypoglycemia) for health: protocol with an example of a research grant application. Implement Sci. 2014;9:58.
64. Fenton JJ, Kravitz RL, Jerant A, Paterniti DA, Bang H, Williams D, Epstein RM, Franks P. Promoting patient-centered counseling to reduce use of low-value diagnostic tests: a randomized clinical trial. JAMA Intern Med. 2016;176:191-7.
65. Martin P, Tamblyn R, Ahmed S, Benedetti A, Tannenbaum C. A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial. Trials. 2015;16:266.
66. Winchester DE, Schmalfuss C, Helfrich CD, Beyth RJ. A specialty-specific, multimodality educational quality improvement initiative to deimplement rarely appropriate myocardial perfusion imaging. Open Heart. 2017;4:e000589.
67. Rogers EM. Diffusion of innovations: Simon and Schuster; 2010.
68. Norton WE, Kennedy A, Chambers DA. Studying de-implementation in health: an analysis of funded research grants. Implement Sci. in press;
69. Kimberly JR. Managerial innovation. Handb Organ Des. 1981;1:104.